Corvus hawaiiensis isolate bCorHaw1 chromosome 15, bCorHaw1.pri.cur, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Corvoidea; Corvidae; Corvus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036360.1.\nAssembly name: bCorHaw1.pri.cur\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGSY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 20-SEP-2021\nAssembly Method :: HiFiasm v. 0.15.4+galaxy; purge_dups v.\n 1.2.5+galaxy3; Bionano Solve v.\n 3.6.1+galaxy2; Salsa v. 2.3+galaxy0;\n gEVAL manual curation v. 2021-09-20; VGP\n pipeline v. 2.0\nAssembly Name :: bCorHaw1.pri.cur\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 29.61x\nSequencing Technology :: PacBio Sequel II HiFi; Illumina NovaSeq;\n Bionano Genomics Saphyr DLS; Arima\n Genomics Hi-C v2\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Corvus hawaiiensis Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125333928, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC125333928, transcript variant X2
uncharacterized LOC125333928, transcript variant X1
uncharacterized LOC125333615, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC125333615, transcript variant X1
uncharacterized LOC125333742, transcript variant X1
uncharacterized LOC125333742, transcript variant X2
receptor accessory protein 2, transcript variant X1
receptor accessory protein 2, transcript variant X2
receptor accessory protein 2, transcript variant X4
receptor accessory protein 2, transcript variant X3
receptor expression-enhancing protein 2 isoform X1
receptor expression-enhancing protein 2 isoform X4
receptor expression-enhancing protein 2 isoform X3
receptor expression-enhancing protein 2 isoform X2
lysine demethylase 3B, transcript variant X2
lysine demethylase 3B, transcript variant X1
lysine-specific demethylase 3B isoform X2
lysine-specific demethylase 3B isoform X1
lysine demethylase 3B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
C-terminal-binding protein 2, transcript variant X1
C-terminal-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cell division cycle 23, transcript variant X2
cell division cycle 23, transcript variant X1
cell division cycle protein 23 homolog isoform X1
cell division cycle protein 23 homolog isoform X2
janus kinase and microtubule interacting protein 2, transcript variant X1
janus kinase and microtubule interacting protein 2, transcript variant X3
janus kinase and microtubule interacting protein 2, transcript variant X2
janus kinase and microtubule interacting protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
janus kinase and microtubule-interacting protein 2 isoform X1
janus kinase and microtubule-interacting protein 2 isoform X2
dihydropyrimidinase like 3, transcript variant X1
dihydropyrimidinase-related protein 3 isoform X1
dihydropyrimidinase like 3, transcript variant X2
dihydropyrimidinase-related protein 3 isoform X2
serine/threonine kinase 32A, transcript variant X1
serine/threonine-protein kinase 32A isoform X1
serine/threonine kinase 32A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase 32A isoform X2
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X2
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X3
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X3
transcription elongation regulator 1, transcript variant X1
transcription elongation regulator 1, transcript variant X5
transcription elongation regulator 1, transcript variant X4
transcription elongation regulator 1, transcript variant X3
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1 isoform X5
transcription elongation regulator 1 isoform X4
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
POU domain, class 4, transcription factor 3
RNA binding motif protein 27, transcript variant X2
RNA binding motif protein 27, transcript variant X3
RNA binding motif protein 27, transcript variant X1
glutaredoxin and cysteine rich domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
glutaredoxin domain-containing cysteine-rich protein 2
uncharacterized LOC125333901, transcript variant X2
uncharacterized LOC125333901, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125333901, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125333901, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125333901, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium channel tetramerization domain containing 16
BTB/POZ domain-containing protein KCTD16
Yip1 domain family member 5, transcript variant X1
Yip1 domain family member 5, transcript variant X2
nuclear receptor subfamily 3 group C member 1, transcript variant X1
nuclear receptor subfamily 3 group C member 1, transcript variant X2
Rho GTPase activating protein 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
rho GTPase-activating protein 26 isoform X2
rho GTPase-activating protein 26 isoform X1
Rho GTPase activating protein 26, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
rho GTPase-activating protein 26 isoform X3
Rho GTPase activating protein 26, transcript variant X4
rho GTPase-activating protein 26 isoform X4
fibroblast growth factor 1, transcript variant X3
fibroblast growth factor 1, transcript variant X1
fibroblast growth factor 1, transcript variant X2
uncharacterized LOC125333652, transcript variant X8
uncharacterized LOC125333652, transcript variant X2
uncharacterized LOC125333652, transcript variant X7
uncharacterized LOC125333652, transcript variant X6
uncharacterized LOC125333652, transcript variant X1
uncharacterized LOC125333652, transcript variant X4
uncharacterized LOC125333652, transcript variant X5
uncharacterized LOC125333652, transcript variant X3
ring finger protein 14, transcript variant X3
ring finger protein 14, transcript variant X2
ring finger protein 14, transcript variant X1
ring finger protein 14, transcript variant X4
E3 ubiquitin-protein ligase RNF14 isoform X1
E3 ubiquitin-protein ligase RNF14 isoform X2
heat shock protein family A (Hsp70) member 4, transcript variant X1
heat shock protein family A (Hsp70) member 4, transcript variant X2
zinc finger CCHC domain-containing protein 10
growth differentiation factor 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
growth differentiation factor 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X1
PWWP domain containing 2A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X5
PWWP domain containing 2A, transcript variant X4
PWWP domain containing 2A, transcript variant X6
PWWP domain containing 2A, transcript variant X7
PWWP domain-containing protein 2A isoform X3
PWWP domain-containing protein 2A isoform X2
PWWP domain-containing protein 2A isoform X1
tetratricopeptide repeat domain 1, transcript variant X1
tetratricopeptide repeat domain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
5-hydroxytryptamine receptor 4, transcript variant X1
5-hydroxytryptamine receptor 4, transcript variant X2
5-hydroxytryptamine receptor 4, transcript variant X3
5-hydroxytryptamine receptor 4, transcript variant X5
5-hydroxytryptamine receptor 4 isoform X1
5-hydroxytryptamine receptor 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5-hydroxytryptamine receptor 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X3
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X1
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X1
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X3
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X2
tripartite motif-containing protein 29-like
peroxisome proliferator-activated receptor gamma coactivator 1-beta
Rho guanine nucleotide exchange factor 37, transcript variant X1
Rho guanine nucleotide exchange factor 37, transcript variant X2
rho guanine nucleotide exchange factor 37 isoform X1
rho guanine nucleotide exchange factor 37 isoform X2
casein kinase 1 alpha 1, transcript variant X1
casein kinase 1 alpha 1, transcript variant X3
casein kinase 1 alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
casein kinase 1 alpha 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
GrpE like 2, mitochondrial, transcript variant X1
GrpE like 2, mitochondrial, transcript variant X3
grpE protein homolog 2, mitochondrial isoform X1
grpE protein homolog 2, mitochondrial isoform X3
GrpE like 2, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
grpE protein homolog 2, mitochondrial isoform X2
actin filament associated protein 1 like 1, transcript variant X6
actin filament associated protein 1 like 1, transcript variant X5
actin filament associated protein 1 like 1, transcript variant X4
actin filament associated protein 1 like 1, transcript variant X3
actin filament associated protein 1 like 1, transcript variant X2
actin filament associated protein 1 like 1, transcript variant X1
actin filament-associated protein 1-like 1 isoform X6
actin filament-associated protein 1-like 1 isoform X5
actin filament-associated protein 1-like 1 isoform X4
actin filament-associated protein 1-like 1 isoform X3
actin filament-associated protein 1-like 1 isoform X2
actin filament-associated protein 1-like 1 isoform X1
actin binding LIM protein family member 3, transcript variant X5
actin binding LIM protein family member 3, transcript variant X4
actin binding LIM protein family member 3, transcript variant X3
actin binding LIM protein family member 3, transcript variant X2
actin binding LIM protein family member 3, transcript variant X1
actin binding LIM protein family member 3, transcript variant X8
actin binding LIM protein family member 3, transcript variant X7
actin binding LIM protein family member 3, transcript variant X6
actin binding LIM protein family member 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X10
SH3 domain and tetratricopeptide repeats 2, transcript variant X7
SH3 domain and tetratricopeptide repeats 2, transcript variant X2
SH3 domain and tetratricopeptide repeats 2, transcript variant X5
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X2
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X5
SH3 domain and tetratricopeptide repeats 2, transcript variant X3
SH3 domain and tetratricopeptide repeats 2, transcript variant X6
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X3
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X6
SH3 domain and tetratricopeptide repeats 2, transcript variant X4
SH3 domain and tetratricopeptide repeats 2, transcript variant X1
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X1
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X4
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
ubiquitin domain containing 2, transcript variant X1
ubiquitin domain-containing protein 2 isoform X1
ubiquitin domain containing 2, transcript variant X2
ubiquitin domain-containing protein 2 isoform X2
serine/threonine kinase 10, transcript variant X1
serine/threonine kinase 10, transcript variant X2
serine/threonine-protein kinase 10 isoform X1
serine/threonine-protein kinase 10 isoform X2
SH3 and PX domains 2B, transcript variant X1
SH3 and PX domains 2B, transcript variant X2
SH3 and PX domains 2B, transcript variant X6
SH3 and PX domains 2B, transcript variant X3
SH3 and PX domains 2B, transcript variant X4
SH3 and PX domain-containing protein 2B isoform X1
SH3 and PX domain-containing protein 2B isoform X3
SH3 and PX domain-containing protein 2B isoform X2
SH3 and PX domain-containing protein 2B isoform X4
SH3 and PX domain-containing protein 2B isoform X6
SH3 and PX domains 2B, transcript variant X5
SH3 and PX domain-containing protein 2B isoform X5
neuralized E3 ubiquitin protein ligase 1B
endoplasmic reticulum-golgi intermediate compartment 1
endoplasmic reticulum-Golgi intermediate compartment protein 1
CREB3 regulatory factor, transcript variant X3
CREB3 regulatory factor, transcript variant X2
CREB3 regulatory factor, transcript variant X1
biorientation of chromosomes in cell division 1
biorientation of chromosomes in cell division protein 1
cytoplasmic polyadenylation element binding protein 4, transcript variant X1
cytoplasmic polyadenylation element binding protein 4, transcript variant X2
cytoplasmic polyadenylation element-binding protein 4 isoform X1
cytoplasmic polyadenylation element-binding protein 4 isoform X2
neuronal vesicle trafficking associated 2
neuronal vesicle trafficking-associated protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dopamine receptor D1, transcript variant X1
dopamine receptor D1, transcript variant X3
dopamine receptor D1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
bromodomain containing 8, transcript variant X1
bromodomain containing 8, transcript variant X2
bromodomain-containing protein 8 isoform X1
bromodomain-containing protein 8 isoform X2
bromodomain-containing protein 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
bromodomain-containing protein 8-like, transcript variant X1
bromodomain-containing protein 8-like, transcript variant X3
bromodomain-containing protein 8-like isoform X1
bromodomain-containing protein 8-like isoform X2
H/ACA ribonucleoprotein complex subunit 2
NEDD4 binding protein 3, transcript variant X2
NEDD4 binding protein 3, transcript variant X1
vesicular integral-membrane protein VIP36
ADP-ribosylation factor-like protein 3, transcript variant X4
ADP-ribosylation factor-like protein 3, transcript variant X3
ADP-ribosylation factor-like protein 3, transcript variant X2
ADP-ribosylation factor-like protein 3, transcript variant X1
ADP-ribosylation factor-like protein 3 isoform X3
ADP-ribosylation factor-like protein 3 isoform X2
ADP-ribosylation factor-like protein 3 isoform X1
regulator of G protein signaling 14, transcript variant X3
regulator of G protein signaling 14, transcript variant X4
regulator of G protein signaling 14, transcript variant X1
regulator of G protein signaling 14, transcript variant X2
regulator of G protein signaling 14, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
regulator of G-protein signaling 14 isoform X3
regulator of G-protein signaling 14 isoform X4
regulator of G-protein signaling 14 isoform X1
regulator of G-protein signaling 14 isoform X2
regulator of G-protein signaling 14 isoform X5
sodium-dependent phosphate transport protein 2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
G protein-coupled receptor kinase 6, transcript variant X2
G protein-coupled receptor kinase 6, transcript variant X1
G protein-coupled receptor kinase 6, transcript variant X3
G protein-coupled receptor kinase 6 isoform X1
G protein-coupled receptor kinase 6 isoform X3
G protein-coupled receptor kinase 6 isoform X2
proline rich 7, synaptic, transcript variant X1
proline rich 7, synaptic, transcript variant X2
PDZ and LIM domain 7, transcript variant X1
PDZ and LIM domain 7, transcript variant X4
PDZ and LIM domain 7, transcript variant X2
PDZ and LIM domain 7, transcript variant X3
PDZ and LIM domain 7, transcript variant X5
PDZ and LIM domain 7, transcript variant X6
PDZ and LIM domain 7, transcript variant X12
PDZ and LIM domain 7, transcript variant X9
PDZ and LIM domain 7, transcript variant X8
PDZ and LIM domain 7, transcript variant X11
PDZ and LIM domain 7, transcript variant X7
PDZ and LIM domain protein 7 isoform X12
PDZ and LIM domain protein 7 isoform X11
PDZ and LIM domain 7, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PDZ and LIM domain protein 7 isoform X10
probable ATP-dependent RNA helicase DDX41
family with sequence similarity 193 member B, transcript variant X2
family with sequence similarity 193 member B, transcript variant X1
lateral signaling target protein 2 homolog, transcript variant X1
lateral signaling target protein 2 homolog, transcript variant X3
lateral signaling target protein 2 homolog, transcript variant X2
lateral signaling target protein 2 homolog isoform X1
lateral signaling target protein 2 homolog isoform X2
lateral signaling target protein 2 homolog isoform X3
MAX dimerization protein 3, transcript variant X1
MAX dimerization protein 3, transcript variant X2
PRELI domain-containing protein 1, mitochondrial
nuclear receptor binding SET domain protein 1, transcript variant X1
nuclear receptor binding SET domain protein 1, transcript variant X2
nuclear receptor binding SET domain protein 1, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-36 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-36 specific isoform X3
histone-lysine N-methyltransferase, H3 lysine-36 specific isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
fibroblast growth factor receptor 4, transcript variant X4
fibroblast growth factor receptor 4, transcript variant X3
fibroblast growth factor receptor 4, transcript variant X1
fibroblast growth factor receptor 4, transcript variant X2
fibroblast growth factor receptor 4 isoform X3
fibroblast growth factor receptor 4 isoform X2
fibroblast growth factor receptor 4 isoform X1
ubiquitin interaction motif containing 1, transcript variant X3
ubiquitin interaction motif containing 1, transcript variant X1
ubiquitin interaction motif containing 1, transcript variant X5
ubiquitin interaction motif containing 1, transcript variant X4
ubiquitin interaction motif containing 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ubiquitin interaction motif containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin interaction motif containing 1, transcript variant X8
ubiquitin interaction motif containing 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin interaction motif containing 1, transcript variant X2
BRCA1-A complex subunit RAP80 isoform X1
BRCA1-A complex subunit RAP80 isoform X3
BRCA1-A complex subunit RAP80 isoform X2
BRCA1-A complex subunit RAP80 isoform X4
BRCA1-A complex subunit RAP80 isoform X5
BRCA1-A complex subunit RAP80 isoform X6
BRCA1-A complex subunit RAP80 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E family member 1B, transcript variant X2
eukaryotic translation initiation factor 4E family member 1B, transcript variant X1
eukaryotic translation initiation factor 4E type 1B isoform X2
eukaryotic translation initiation factor 4E type 1B isoform X1
G protein regulated inducer of neurite outgrowth 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
G protein regulated inducer of neurite outgrowth 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
G protein-regulated inducer of neurite outgrowth 1
cadherin related family member 2, transcript variant X2
cadherin related family member 2, transcript variant X1
cadherin related family member 2, transcript variant X3
cadherin-related family member 2 isoform X2
cadherin-related family member 2 isoform X1
cadherin-related family member 2 isoform X3
ring finger protein 44, transcript variant X3
ring finger protein 44, transcript variant X4
ring finger protein 44, transcript variant X2
ring finger protein 44, transcript variant X1
Fas associated factor family member 2, transcript variant X3
Fas associated factor family member 2, transcript variant X1
Fas associated factor family member 2, transcript variant X2
clathrin light chain B, transcript variant X2
clathrin light chain B, transcript variant X1
HIG1 hypoxia inducible domain family member 2A
HIG1 domain family member 2A, mitochondrial
SUMO interacting motifs containing 1, transcript variant X2
SUMO interacting motifs containing 1, transcript variant X1
SUMO-interacting motif-containing protein 1 isoform X2
SUMO-interacting motif-containing protein 1 isoform X1
histamine receptor H2, transcript variant X2
histamine receptor H2, transcript variant X1
histamine receptor H2, transcript variant X3
pancreatic secretory trypsin inhibitor-like
serine protease inhibitor Kazal-type 5-like, transcript variant X2
serine protease inhibitor Kazal-type 5-like, transcript variant X1
serine protease inhibitor Kazal-type 5-like, transcript variant X4
serine protease inhibitor Kazal-type 5-like, transcript variant X3
serine protease inhibitor Kazal-type 5-like isoform X1
serine protease inhibitor Kazal-type 5-like isoform X3
serine protease inhibitor Kazal-type 5-like isoform X2
serine protease inhibitor Kazal-type 5-like isoform X4
ovoinhibitor-like, transcript variant X1
ovoinhibitor-like, transcript variant X2
double-headed protease inhibitor, submandibular gland-like
serine protease inhibitor Kazal-type 6-like
ubiquitin like domain containing CTD phosphatase 1, transcript variant X2
ubiquitin like domain containing CTD phosphatase 1, transcript variant X1
ubiquitin-like domain-containing CTD phosphatase 1
ring finger protein 145, transcript variant X1
ring finger protein 145, transcript variant X3
ring finger protein 145, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
EBF transcription factor 1, transcript variant X1
EBF transcription factor 1, transcript variant X5
EBF transcription factor 1, transcript variant X2
EBF transcription factor 1, transcript variant X6
EBF transcription factor 1, transcript variant X3
EBF transcription factor 1, transcript variant X7
EBF transcription factor 1, transcript variant X4
EBF transcription factor 1, transcript variant X8
EBF transcription factor 1, transcript variant X9
U7 snRNA-associated Sm-like protein LSm11
tRNA-histidine guanylyltransferase 1 like, transcript variant X1
tRNA-histidine guanylyltransferase 1 like, transcript variant X2
tRNA-histidine guanylyltransferase 1 like, transcript variant X3
probable tRNA(His) guanylyltransferase isoform X1
probable tRNA(His) guanylyltransferase isoform X3
probable tRNA(His) guanylyltransferase isoform X2
ADAM metallopeptidase domain 19, transcript variant X1
ADAM metallopeptidase domain 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 19
NIPA like domain containing 4, transcript variant X2
NIPA like domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X3
cytoplasmic FMR1 interacting protein 2, transcript variant X4
cytoplasmic FMR1 interacting protein 2, transcript variant X1
cytoplasmic FMR1 interacting protein 2, transcript variant X2
cytoplasmic FMR1-interacting protein 2 isoform X2
cytoplasmic FMR1-interacting protein 2 isoform X3
cytoplasmic FMR1-interacting protein 2 isoform X1
fibronectin type III domain containing 9
fibronectin type III domain-containing protein 9
mediator complex subunit 7, transcript variant X1
mediator complex subunit 7, transcript variant X2
mediator of RNA polymerase II transcription subunit 7
hepatitis A virus cellular receptor 1 homolog, transcript variant X2
hepatitis A virus cellular receptor 1 homolog, transcript variant X1
hepatitis A virus cellular receptor 1 homolog isoform X1
hepatitis A virus cellular receptor 1 homolog isoform X2
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X2
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X1
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X3
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X1
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X2
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X3
sarcoglycan delta, transcript variant X1
sarcoglycan delta, transcript variant X2
sarcoglycan delta, transcript variant X4
sarcoglycan delta, transcript variant X3
39S ribosomal protein L22, mitochondrial
gem nuclear organelle associated protein 5
CCR4-NOT transcription complex subunit 8, transcript variant X1
CCR4-NOT transcription complex subunit 8, transcript variant X2
CCR4-NOT transcription complex subunit 8
fatty acid hydroxylase domain containing 2, transcript variant X5
fatty acid hydroxylase domain containing 2, transcript variant X2
fatty acid hydroxylase domain containing 2, transcript variant X1
fatty acid hydroxylase domain containing 2, transcript variant X6
fatty acid hydroxylase domain containing 2, transcript variant X7
fatty acid hydroxylase domain containing 2, transcript variant X3
fatty acid hydroxylase domain containing 2, transcript variant X4
fatty acid hydroxylase domain-containing protein 2 isoform X1
fatty acid hydroxylase domain-containing protein 2 isoform X2
La ribonucleoprotein 1, translational regulator, transcript variant X2
La ribonucleoprotein 1, translational regulator, transcript variant X1
uncharacterized LOC125333985, transcript variant X2
uncharacterized LOC125333985, transcript variant X3
uncharacterized LOC125333985, transcript variant X1
heart and neural crest derivatives expressed 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
heart and neural crest derivatives expressed 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
heart- and neural crest derivatives-expressed protein 1 isoform X1
heart- and neural crest derivatives-expressed protein 1 isoform X2
histone deacetylase complex subunit SAP30L
polypeptide N-acetylgalactosaminyltransferase 10
family with sequence similarity 114 member A2
LON peptidase N-terminal domain and RING finger protein 1-like
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X2
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X1
uncharacterized LOC125333795, transcript variant X2
uncharacterized LOC125333795, transcript variant X1
uncharacterized LOC125333795, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
glycine receptor alpha 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
glycine receptor alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
glycine receptor subunit alpha-1 isoform X1
glycine receptor subunit alpha-1 isoform X2
G3BP stress granule assembly factor 1, transcript variant X2
G3BP stress granule assembly factor 1, transcript variant X1
ras GTPase-activating protein-binding protein 1 isoform X2
ras GTPase-activating protein-binding protein 1 isoform X1
secreted protein acidic and cysteine rich, transcript variant X1
secreted protein acidic and cysteine rich, transcript variant X2
proton-coupled amino acid transporter 1-like
ganglioside GM2 activator, transcript variant X2
ganglioside GM2 activator, transcript variant X1
coiled-coil domain containing 69, transcript variant X3
coiled-coil domain containing 69, transcript variant X1
coiled-coil domain containing 69, transcript variant X2
coiled-coil domain-containing protein 69 isoform X1
coiled-coil domain-containing protein 69 isoform X3
coiled-coil domain-containing protein 69 isoform X2
cationic amino acid transporter 2-like, transcript variant X2
cationic amino acid transporter 2-like isoform X2
cationic amino acid transporter 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cationic amino acid transporter 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cationic amino acid transporter 2-like isoform X1
cationic amino acid transporter 2-like isoform X3
TNFAIP3 interacting protein 1, transcript variant X2
TNFAIP3 interacting protein 1, transcript variant X1
TNFAIP3 interacting protein 1, transcript variant X3
TNFAIP3 interacting protein 1, transcript variant X4
TNFAIP3-interacting protein 1 isoform X1
TNFAIP3-interacting protein 1 isoform X2
TNFAIP3-interacting protein 1 isoform X3
dynactin subunit 4, transcript variant X1
dynactin subunit 4, transcript variant X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
HLA class II histocompatibility antigen gamma chain isoform X1
HLA class II histocompatibility antigen gamma chain isoform X2
treacle ribosome biogenesis factor 1, transcript variant X3
treacle ribosome biogenesis factor 1, transcript variant X2
treacle ribosome biogenesis factor 1, transcript variant X1
calcium/calmodulin dependent protein kinase II alpha, transcript variant X2
calcium/calmodulin dependent protein kinase II alpha, transcript variant X1
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X2
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1
solute carrier family 6 member 7, transcript variant X3
solute carrier family 6 member 7, transcript variant X2
solute carrier family 6 member 7, transcript variant X1
sodium-dependent proline transporter isoform X3
sodium-dependent proline transporter isoform X2
sodium-dependent proline transporter isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
platelet derived growth factor receptor beta, transcript variant X1
platelet derived growth factor receptor beta, transcript variant X2
platelet-derived growth factor receptor beta
macrophage colony-stimulating factor 1 receptor
HMG-box containing 3, transcript variant X3
HMG-box containing 3, transcript variant X2
HMG-box containing 3, transcript variant X1
HMG domain-containing protein 3 isoform X3
HMG domain-containing protein 3 isoform X2
HMG domain-containing protein 3 isoform X1
E3 ubiquitin-protein ligase makorin-2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 2 codons; deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase makorin-2-like
neuropeptide Y receptor type 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
neuropeptide Y receptor type 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neuropeptide Y receptor type 2-like isoform X1
neuropeptide Y receptor type 2-like isoform X2
zinc-binding protein A33-like, transcript variant X3
zinc-binding protein A33-like, transcript variant X2
zinc-binding protein A33-like, transcript variant X4
zinc-binding protein A33-like, transcript variant X1
fms related receptor tyrosine kinase 4, transcript variant X1
fms related receptor tyrosine kinase 4, transcript variant X2
fms related receptor tyrosine kinase 4, transcript variant X5
fms related receptor tyrosine kinase 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
vascular endothelial growth factor receptor 3 isoform X1
vascular endothelial growth factor receptor 3 isoform X2
vascular endothelial growth factor receptor 3 isoform X5
vascular endothelial growth factor receptor 3 isoform X4
fms related receptor tyrosine kinase 4, transcript variant X3
vascular endothelial growth factor receptor 3 isoform X3
ring finger protein 130, transcript variant X4
ring finger protein 130, transcript variant X2
ring finger protein 130, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ring finger protein 130, transcript variant X3
ring finger protein 130, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF130 isoform X4
E3 ubiquitin-protein ligase RNF130 isoform X2
E3 ubiquitin-protein ligase RNF130 isoform X5
E3 ubiquitin-protein ligase RNF130 isoform X1
E3 ubiquitin-protein ligase RNF130 isoform X3
TBC1 domain family member 9B, transcript variant X1
TBC1 domain family member 9B, transcript variant X2
TBC1 domain family member 9B, transcript variant X3
MRN complex interacting protein, transcript variant X1
MRN complex interacting protein, transcript variant X2
MRN complex-interacting protein isoform X1
MRN complex-interacting protein isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X3
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
mastermind like transcriptional coactivator 1, transcript variant X2
mastermind like transcriptional coactivator 1, transcript variant X1
leukotriene C4 synthase-like, transcript variant X1
leukotriene C4 synthase-like, transcript variant X3
leukotriene C4 synthase-like, transcript variant X2
heterogeneous nuclear ribonucleoprotein H1, transcript variant X2
heterogeneous nuclear ribonucleoprotein H1, transcript variant X12
heterogeneous nuclear ribonucleoprotein H1, transcript variant X5
heterogeneous nuclear ribonucleoprotein H1, transcript variant X3
heterogeneous nuclear ribonucleoprotein H1, transcript variant X1
heterogeneous nuclear ribonucleoprotein H1, transcript variant X4
heterogeneous nuclear ribonucleoprotein H1, transcript variant X9
heterogeneous nuclear ribonucleoprotein H1, transcript variant X6
heterogeneous nuclear ribonucleoprotein H1, transcript variant X11
heterogeneous nuclear ribonucleoprotein H1, transcript variant X7
heterogeneous nuclear ribonucleoprotein H1, transcript variant X10
heterogeneous nuclear ribonucleoprotein H isoform X11
heterogeneous nuclear ribonucleoprotein H isoform X1
heterogeneous nuclear ribonucleoprotein H isoform X3
heterogeneous nuclear ribonucleoprotein H isoform X6
heterogeneous nuclear ribonucleoprotein H isoform X2
heterogeneous nuclear ribonucleoprotein H isoform X5
heterogeneous nuclear ribonucleoprotein H isoform X9
heterogeneous nuclear ribonucleoprotein H isoform X10
heterogeneous nuclear ribonucleoprotein H isoform X4
heterogeneous nuclear ribonucleoprotein H isoform X8
deoxycytidine kinase 2, transcript variant X2
deoxycytidine kinase 2, transcript variant X1
heterogeneous nuclear ribonucleoprotein H1, transcript variant X8
heterogeneous nuclear ribonucleoprotein H isoform X7
RUN and FYVE domain containing 1, transcript variant X1
RUN and FYVE domain containing 1, transcript variant X5
RUN and FYVE domain containing 1, transcript variant X3
RUN and FYVE domain containing 1, transcript variant X2
RUN and FYVE domain containing 1, transcript variant X4
RUN and FYVE domain-containing protein 1 isoform X1
RUN and FYVE domain-containing protein 1 isoform X3
RUN and FYVE domain-containing protein 1 isoform X2
ADAM metallopeptidase with thrombospondin type 1 motif 2
A disintegrin and metalloproteinase with thrombospondin motifs 2
uncharacterized LOC125333876, transcript variant X2
uncharacterized LOC125333876, transcript variant X1
uncharacterized protein LOC125333876 isoform X1
uncharacterized protein LOC125333876 isoform X2
CCR4-NOT transcription complex subunit 6, transcript variant X3
CCR4-NOT transcription complex subunit 6, transcript variant X1
CCR4-NOT transcription complex subunit 6, transcript variant X2
CCR4-NOT transcription complex subunit 6 isoform X2
CCR4-NOT transcription complex subunit 6 isoform X1
glutamine-fructose-6-phosphate transaminase 2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2
mitogen-activated protein kinase 9, transcript variant X1
mitogen-activated protein kinase 9, transcript variant X2
mitogen-activated protein kinase 9, transcript variant X3
mitogen-activated protein kinase 9 isoform X1
mitogen-activated protein kinase 9 isoform X2
mitogen-activated protein kinase 9 isoform X3
RasGEF domain family member 1C, transcript variant X1
RasGEF domain family member 1C, transcript variant X3
RasGEF domain family member 1C, transcript variant X4
RasGEF domain family member 1C, transcript variant X2
RasGEF domain family member 1C, transcript variant X5
ras-GEF domain-containing family member 1C isoform X1
ras-GEF domain-containing family member 1C isoform X2
CDC like kinase 4, transcript variant X2
CDC like kinase 4, transcript variant X3
CDC like kinase 4, transcript variant X1
dual specificity protein kinase CLK4 isoform X1
dual specificity protein kinase CLK4 isoform X2
CDC like kinase 4, transcript variant X4
dual specificity protein kinase CLK4 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: collagen alpha-1(XXIII) chain
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X1
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X3
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X3
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X2
5-phosphohydroxy-L-lysine phospho-lyase isoform X2
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X1
5-phosphohydroxy-L-lysine phospho-lyase isoform X1
5-phosphohydroxy-L-lysine phospho-lyase isoform X3
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X2
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X4
heterogeneous nuclear ribonucleoprotein A/B isoform X2
heterogeneous nuclear ribonucleoprotein A/B isoform X1
NME/NM23 family member 5, transcript variant X4
NME/NM23 family member 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
NME/NM23 family member 5, transcript variant X5
NME/NM23 family member 5, transcript variant X1
NME/NM23 family member 5, transcript variant X3
NME/NM23 family member 5, transcript variant X2
nucleoside diphosphate kinase homolog 5 isoform X1
nucleoside diphosphate kinase homolog 5 isoform X2
nucleoside diphosphate kinase homolog 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
thymosin beta-12-like, transcript variant X2
thymosin beta-12-like, transcript variant X1
family with sequence similarity 13 member B, transcript variant X3
family with sequence similarity 13 member B, transcript variant X1
family with sequence similarity 13 member B, transcript variant X2
heterogeneous nuclear ribonucleoprotein A0
kelch like family member 3, transcript variant X2
kelch like family member 3, transcript variant X1
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X2
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1, transcript variant X1
transient receptor potential cation channel subfamily C member 7, transcript variant X2
transient receptor potential cation channel subfamily C member 7, transcript variant X1
short transient receptor potential channel 7 isoform X2
short transient receptor potential channel 7 isoform X1
small integral membrane protein 32, transcript variant X1
small integral membrane protein 32, transcript variant X2
SMAD family member 5, transcript variant X3
SMAD family member 5, transcript variant X1
SMAD family member 5, transcript variant X2
mothers against decapentaplegic homolog 5
transforming growth factor-beta-induced protein ig-h3
F-box/LRR-repeat protein 3-like, transcript variant X1
F-box/LRR-repeat protein 3-like, transcript variant X5
F-box/LRR-repeat protein 3-like, transcript variant X3
F-box/LRR-repeat protein 3-like, transcript variant X2
F-box/LRR-repeat protein 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 25 member 48, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 25 member 48, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 25 member 48 isoform X2
solute carrier family 25 member 48 isoform X1
uncharacterized LOC125333961, transcript variant X3
uncharacterized LOC125333961, transcript variant X1
uncharacterized LOC125333961, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
core histone macro-H2A.1, transcript variant X6
core histone macro-H2A.1, transcript variant X3
core histone macro-H2A.1, transcript variant X2
core histone macro-H2A.1, transcript variant X1
core histone macro-H2A.1, transcript variant X4
core histone macro-H2A.1, transcript variant X5
uncharacterized LOC125333810, transcript variant X2
uncharacterized LOC125333810, transcript variant X1
paired like homeodomain 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
paired like homeodomain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
paired like homeodomain 1, transcript variant X5
paired like homeodomain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
paired like homeodomain 1, transcript variant X4
pterin-4 alpha-carbinolamine dehydratase 2, transcript variant X2
pterin-4 alpha-carbinolamine dehydratase 2, transcript variant X3
pterin-4 alpha-carbinolamine dehydratase 2, transcript variant X1
pterin-4-alpha-carbinolamine dehydratase 2 isoform X3
pterin-4-alpha-carbinolamine dehydratase 2 isoform X2
pterin-4-alpha-carbinolamine dehydratase 2 isoform X1
thioredoxin domain-containing protein 15
chromosome 15 C5orf24 homolog, transcript variant X1
chromosome 15 C5orf24 homolog, transcript variant X2
UPF0461 protein C5orf24 homolog isoform X2
UPF0461 protein C5orf24 homolog isoform X1
probable ATP-dependent RNA helicase DDX46
guided entry of tail-anchored proteins factor CAMLG
SEC24 homolog A, COPII coat complex component, transcript variant X2
SEC24 homolog A, COPII coat complex component, transcript variant X1
secretion associated Ras related GTPase 1B, transcript variant X1
secretion associated Ras related GTPase 1B, transcript variant X3
secretion associated Ras related GTPase 1B, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase Jade-2
ubiquitin conjugating enzyme E2 B, transcript variant X1
ubiquitin conjugating enzyme E2 B, transcript variant X2
ubiquitin-conjugating enzyme E2 B isoform X1
ubiquitin-conjugating enzyme E2 B isoform X2
protein phosphatase 2 catalytic subunit alpha
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
S-phase kinase associated protein 1, transcript variant X1
S-phase kinase associated protein 1, transcript variant X3
S-phase kinase associated protein 1, transcript variant X2
transcription factor 7, transcript variant X2
transcription factor 7, transcript variant X1
transcription factor 7, transcript variant X3
transcription factor 7, transcript variant X4
transcription factor 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
transcription factor 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
voltage-dependent anion-selective channel protein 1
keratinocyte-associated transmembrane protein 2
follistatin like 4, transcript variant X1
follistatin like 4, transcript variant X4
follistatin like 4, transcript variant X6
follistatin like 4, transcript variant X3
follistatin like 4, transcript variant X2
follistatin like 4, transcript variant X5
follistatin-related protein 4 isoform X1
follistatin-related protein 4 isoform X2
follistatin-related protein 4 isoform X4
follistatin-related protein 4 isoform X3
Rap guanine nucleotide exchange factor 6, transcript variant X11
Rap guanine nucleotide exchange factor 6, transcript variant X6
Rap guanine nucleotide exchange factor 6, transcript variant X10
Rap guanine nucleotide exchange factor 6, transcript variant X5
Rap guanine nucleotide exchange factor 6, transcript variant X8
Rap guanine nucleotide exchange factor 6, transcript variant X4
Rap guanine nucleotide exchange factor 6, transcript variant X2
Rap guanine nucleotide exchange factor 6, transcript variant X7
Rap guanine nucleotide exchange factor 6, transcript variant X3
Rap guanine nucleotide exchange factor 6, transcript variant X9
Rap guanine nucleotide exchange factor 6, transcript variant X1
Rap guanine nucleotide exchange factor 6, transcript variant X12
rap guanine nucleotide exchange factor 6 isoform X8
rap guanine nucleotide exchange factor 6 isoform X4
rap guanine nucleotide exchange factor 6 isoform X11
rap guanine nucleotide exchange factor 6 isoform X6
rap guanine nucleotide exchange factor 6 isoform X2
rap guanine nucleotide exchange factor 6 isoform X7
rap guanine nucleotide exchange factor 6 isoform X3
rap guanine nucleotide exchange factor 6 isoform X10
rap guanine nucleotide exchange factor 6 isoform X5
rap guanine nucleotide exchange factor 6 isoform X9
rap guanine nucleotide exchange factor 6 isoform X1
rap guanine nucleotide exchange factor 6 isoform X12
folliculin interacting protein 1, transcript variant X1
folliculin interacting protein 1, transcript variant X4
folliculin interacting protein 1, transcript variant X2
folliculin interacting protein 1, transcript variant X3
folliculin-interacting protein 1 isoform X4
folliculin-interacting protein 1 isoform X1
folliculin-interacting protein 1 isoform X3
folliculin-interacting protein 1 isoform X2
meiotic kinetochore factor, transcript variant X1
meiotic kinetochore factor, transcript variant X4
meiotic kinetochore factor, transcript variant X5
meiotic kinetochore factor, transcript variant X3
meiotic kinetochore factor, transcript variant X2
meiosis-specific kinetochore protein isoform X1
meiosis-specific kinetochore protein isoform X4
meiosis-specific kinetochore protein isoform X5
meiosis-specific kinetochore protein isoform X2
meiosis-specific kinetochore protein isoform X3
acyl-CoA synthetase long chain family member 6, transcript variant X5
acyl-CoA synthetase long chain family member 6, transcript variant X1
acyl-CoA synthetase long chain family member 6, transcript variant X3
acyl-CoA synthetase long chain family member 6, transcript variant X2
acyl-CoA synthetase long chain family member 6, transcript variant X6
acyl-CoA synthetase long chain family member 6, transcript variant X7
acyl-CoA synthetase long chain family member 6, transcript variant X4
long-chain-fatty-acid--CoA ligase 6 isoform X3
long-chain-fatty-acid--CoA ligase 6 isoform X2
long-chain-fatty-acid--CoA ligase 6 isoform X1
long-chain-fatty-acid--CoA ligase 6 isoform X5
long-chain-fatty-acid--CoA ligase 6 isoform X4
prolyl 4-hydroxylase subunit alpha 2, transcript variant X4
prolyl 4-hydroxylase subunit alpha 2, transcript variant X3
prolyl 4-hydroxylase subunit alpha 2, transcript variant X1
prolyl 4-hydroxylase subunit alpha 2, transcript variant X2
prolyl 4-hydroxylase subunit alpha 2, transcript variant X5
prolyl 4-hydroxylase subunit alpha-2 isoform X4
prolyl 4-hydroxylase subunit alpha-2 isoform X3
prolyl 4-hydroxylase subunit alpha-2 isoform X1
prolyl 4-hydroxylase subunit alpha-2 isoform X2
prolyl 4-hydroxylase subunit alpha-2 isoform X5
solute carrier family 22 member 4, transcript variant X2
solute carrier family 22 member 4, transcript variant X1
solute carrier family 22 member 4, transcript variant X3
solute carrier family 22 member 4 isoform X1
solute carrier family 22 member 4 isoform X2
solute carrier family 22 member 4 isoform X3
interferon regulatory factor 1, transcript variant X1
interferon regulatory factor 1, transcript variant X2
interferon regulatory factor 1 isoform X1
interferon regulatory factor 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
RAD50 double strand break repair protein, transcript variant X2
RAD50 double strand break repair protein, transcript variant X1
kinesin family member 3A, transcript variant X4
kinesin family member 3A, transcript variant X3
kinesin family member 3A, transcript variant X2
kinesin family member 3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 27% coverage of the annotated genomic feature by RNAseq alignments
sosondowah ankyrin repeat domain family member A
ankyrin repeat domain-containing protein SOWAHA
shroom family member 1, transcript variant X4
shroom family member 1, transcript variant X7
shroom family member 1, transcript variant X2
shroom family member 1, transcript variant X1
shroom family member 1, transcript variant X6
shroom family member 1, transcript variant X3
shroom family member 1, transcript variant X5
shroom family member 1, transcript variant X11
shroom family member 1, transcript variant X10
shroom family member 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
shroom family member 1, transcript variant X8
SLU7 homolog, splicing factor, transcript variant X2
SLU7 homolog, splicing factor, transcript variant X3
SLU7 homolog, splicing factor, transcript variant X1
pre-mRNA-splicing factor SLU7 isoform X2
pre-mRNA-splicing factor SLU7 isoform X1
PTTG1 regulator of sister chromatid separation, securin
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
ATPase phospholipid transporting 10B (putative), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phospholipid-transporting ATPase VB isoform X2
ATPase phospholipid transporting 10B (putative), transcript variant X1
phospholipid-transporting ATPase VB isoform X1
gamma-aminobutyric acid type A receptor subunit beta2, transcript variant X3
gamma-aminobutyric acid type A receptor subunit beta2, transcript variant X2
gamma-aminobutyric acid type A receptor subunit beta2, transcript variant X4
gamma-aminobutyric acid type A receptor subunit beta2, transcript variant X1
gamma-aminobutyric acid receptor subunit beta-2 isoform X2
gamma-aminobutyric acid receptor subunit beta-2 isoform X1
gamma-aminobutyric acid type A receptor subunit alpha6, transcript variant X2
gamma-aminobutyric acid type A receptor subunit alpha6, transcript variant X1
gamma-aminobutyric acid type A receptor subunit alpha6, transcript variant X3
gamma-aminobutyric acid receptor subunit alpha-6 isoform X1
gamma-aminobutyric acid receptor subunit alpha-6 isoform X2
gamma-aminobutyric acid receptor subunit alpha-6 isoform X3
gamma-aminobutyric acid type A receptor subunit alpha1, transcript variant X1
gamma-aminobutyric acid type A receptor subunit alpha1, transcript variant X3
gamma-aminobutyric acid type A receptor subunit alpha1, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-1
gamma-aminobutyric acid type A receptor subunit gamma2, transcript variant X1
gamma-aminobutyric acid type A receptor subunit gamma2, transcript variant X2
gamma-aminobutyric acid receptor subunit gamma-2 isoform X1
gamma-aminobutyric acid receptor subunit gamma-2 isoform X2
methionine adenosyltransferase 2B, transcript variant X2
methionine adenosyltransferase 2 subunit beta isoform X2
methionine adenosyltransferase 2B, transcript variant X1
methionine adenosyltransferase 2B, transcript variant X3
methionine adenosyltransferase 2 subunit beta isoform X1
methionine adenosyltransferase 2 subunit beta isoform X3
uncharacterized LOC125333962, transcript variant X2
uncharacterized LOC125333962, transcript variant X1
teneurin transmembrane protein 2, transcript variant X2
teneurin transmembrane protein 2, transcript variant X1
teneurin transmembrane protein 2, transcript variant X5
teneurin transmembrane protein 2, transcript variant X3
teneurin transmembrane protein 2, transcript variant X4
WW and C2 domain containing 1, transcript variant X1
WW and C2 domain containing 1, transcript variant X2
arginyl-tRNA synthetase 1, transcript variant X1
arginine--tRNA ligase, cytoplasmic isoform X1
arginyl-tRNA synthetase 1, transcript variant X2
arginine--tRNA ligase, cytoplasmic isoform X2
rho GTPase-activating protein 7-like, transcript variant X2
rho GTPase-activating protein 7-like, transcript variant X1
rho GTPase-activating protein 7-like, transcript variant X8
rho GTPase-activating protein 7-like, transcript variant X6
rho GTPase-activating protein 7-like, transcript variant X5
rho GTPase-activating protein 7-like, transcript variant X4
rho GTPase-activating protein 7-like, transcript variant X7
rho GTPase-activating protein 7-like, transcript variant X9
rho GTPase-activating protein 7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 7-like isoform X1
rho GTPase-activating protein 7-like isoform X5
rho GTPase-activating protein 7-like isoform X4
rho GTPase-activating protein 7-like isoform X3
rho GTPase-activating protein 7-like isoform X6
rho GTPase-activating protein 7-like isoform X7
rho GTPase-activating protein 7-like isoform X2
pantothenate kinase 3, transcript variant X2
pantothenate kinase 3, transcript variant X1
slit guidance ligand 3, transcript variant X1
slit guidance ligand 3, transcript variant X2
spindle apparatus coiled-coil protein 1, transcript variant X1
spindle apparatus coiled-coil protein 1, transcript variant X2
spindle apparatus coiled-coil protein 1, transcript variant X3
inhibitory synaptic factor family member 2B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
DND microRNA-mediated repression inhibitor 1
WD repeat domain 55, transcript variant X3
WD repeat domain 55, transcript variant X4
WD repeat domain 55, transcript variant X2
WD repeat domain 55, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
WD repeat domain 55, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WD repeat-containing protein 55 isoform X2
WD repeat-containing protein 55 isoform X1
NADH:ubiquinone oxidoreductase subunit A2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
transmembrane and coiled-coil domains 6, transcript variant X3
transmembrane and coiled-coil domains 6, transcript variant X2
transmembrane and coiled-coil domains 6, transcript variant X1
transmembrane and coiled-coil domain-containing protein 6 isoform X3
transmembrane and coiled-coil domain-containing protein 6 isoform X2
transmembrane and coiled-coil domain-containing protein 6 isoform X1
transmembrane and coiled-coil domains 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 6 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
probable UDP-sugar transporter protein SLC35A4
stimulator of interferon response cGAMP interactor 1, transcript variant X3
stimulator of interferon response cGAMP interactor 1, transcript variant X4
stimulator of interferon response cGAMP interactor 1, transcript variant X2
stimulator of interferon response cGAMP interactor 1, transcript variant X1
stimulator of interferon genes protein isoform X3
stimulator of interferon genes protein isoform X4
stimulator of interferon genes protein isoform X2
stimulator of interferon genes protein isoform X1
CXXC finger protein 5, transcript variant X1
CXXC finger protein 5, transcript variant X2
CXXC-type zinc finger protein 5 isoform X1
CXXC-type zinc finger protein 5 isoform X2
uncharacterized LOC125333920, transcript variant X1
uncharacterized LOC125333920, transcript variant X2
pleckstrin and Sec7 domain containing 2, transcript variant X2
pleckstrin and Sec7 domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
pleckstrin and Sec7 domain containing 2, transcript variant X3
pleckstrin and Sec7 domain containing 2, transcript variant X1
PH and SEC7 domain-containing protein 2 isoform X1
PH and SEC7 domain-containing protein 2 isoform X2
PH and SEC7 domain-containing protein 2 isoform X3
pro-neuregulin-2, membrane-bound isoform isoform X4
pro-neuregulin-2, membrane-bound isoform isoform X2
pro-neuregulin-2, membrane-bound isoform isoform X3
pro-neuregulin-2, membrane-bound isoform isoform X1
uncharacterized LOC125333948, transcript variant X2
uncharacterized LOC125333948, transcript variant X1
uncharacterized LOC125333911, transcript variant X2
uncharacterized LOC125333911, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
transcriptional activator protein Pur-alpha
cysteine rich transmembrane module containing 1, transcript variant X1
cysteine-rich and transmembrane domain-containing protein 1 isoform X1
cysteine rich transmembrane module containing 1, transcript variant X2
cysteine rich transmembrane module containing 1, transcript variant X4
cysteine rich transmembrane module containing 1, transcript variant X3
cysteine-rich and transmembrane domain-containing protein 1 isoform X2
heparin binding EGF like growth factor, transcript variant X2
heparin binding EGF like growth factor, transcript variant X1
proheparin-binding EGF-like growth factor isoform X2
proheparin-binding EGF-like growth factor isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and KH domain containing 1, transcript variant X1
ankyrin repeat and KH domain containing 1, transcript variant X2
ankyrin repeat and KH domain containing 1, transcript variant X3
ankyrin repeat and KH domain containing 1, transcript variant X4
ankyrin repeat and KH domain containing 1, transcript variant X5
ankyrin repeat and KH domain containing 1, transcript variant X6
ankyrin repeat and KH domain containing 1, transcript variant X7
ankyrin repeat and KH domain containing 1, transcript variant X8
ankyrin repeat and KH domain-containing protein 1 isoform X1
ankyrin repeat and KH domain-containing protein 1 isoform X2
ankyrin repeat and KH domain-containing protein 1 isoform X3
ankyrin repeat and KH domain-containing protein 1 isoform X4
ankyrin repeat and KH domain-containing protein 1 isoform X5
ankyrin repeat and KH domain-containing protein 1 isoform X6
ankyrin repeat and KH domain-containing protein 1 isoform X7
ankyrin repeat and KH domain-containing protein 1 isoform X8
amyloid beta precursor protein binding family B member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
amyloid beta precursor protein binding family B member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
amyloid-beta A4 precursor protein-binding family B member 3 isoform X2
amyloid-beta A4 precursor protein-binding family B member 3 isoform X1
histidine--tRNA ligase, cytoplasmic-like
histidine--tRNA ligase, cytoplasmic-like, transcript variant X2
histidine--tRNA ligase, cytoplasmic-like, transcript variant X1
histidine--tRNA ligase, cytoplasmic-like isoform X2
histidine--tRNA ligase, cytoplasmic-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protocadherin alpha-C2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X3
protocadherin alpha-C2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 215 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 165 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 158 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 217 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC125333966
protocadherin gamma-A2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protocadherin gamma-A2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 151 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC125333826, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
uncharacterized LOC125333826, transcript variant X3
uncharacterized LOC125333826, transcript variant X2
uncharacterized LOC125333826, transcript variant X1
uncharacterized LOC125333826, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125333826, transcript variant X10
uncharacterized LOC125333826, transcript variant X8
uncharacterized LOC125333826, transcript variant X4
uncharacterized LOC125333826, transcript variant X5
uncharacterized LOC125333826, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125333826, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized protein LOC125333826 isoform X4
uncharacterized protein LOC125333826 isoform X3
uncharacterized protein LOC125333826 isoform X2
uncharacterized protein LOC125333826 isoform X1
uncharacterized protein LOC125333826 isoform X5
uncharacterized LOC125333825, transcript variant X1
uncharacterized LOC125333825, transcript variant X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: proteinase-activated receptor 3-like
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X3
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
small integral membrane protein 33, transcript variant X3
small integral membrane protein 33, transcript variant X2
small integral membrane protein 33, transcript variant X1
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X1
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X3
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
endothelial cell-specific chemotaxis regulator isoform X1
endothelial cell-specific chemotaxis regulator isoform X3
endothelial cell-specific chemotaxis regulator isoform X2
DnaJ heat shock protein family (Hsp40) member C18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
marginal zone B and B1 cell specific protein
marginal zone B- and B1-cell-specific protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: solute carrier family 23 member 1
poly(A) binding protein interacting protein 2, transcript variant X2
poly(A) binding protein interacting protein 2, transcript variant X1
polyadenylate-binding protein-interacting protein 2
uncharacterized LOC125333941, transcript variant X2
uncharacterized LOC125333941, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00090
SIL1 nucleotide exchange factor, transcript variant X3
SIL1 nucleotide exchange factor, transcript variant X2
SIL1 nucleotide exchange factor, transcript variant X1
nucleotide exchange factor SIL1 isoform X1
nucleotide exchange factor SIL1 isoform X2
leucine rich repeat transmembrane neuronal 2, transcript variant X1
leucine rich repeat transmembrane neuronal 2, transcript variant X3
leucine rich repeat transmembrane neuronal 2, transcript variant X2
leucine-rich repeat transmembrane neuronal protein 2 isoform X2
leucine-rich repeat transmembrane neuronal protein 2 isoform X3
leucine-rich repeat transmembrane neuronal protein 2 isoform X1
uncharacterized LOC125333767, transcript variant X2
uncharacterized LOC125333767, transcript variant X1
heat shock protein family A (Hsp70) member 9, transcript variant X2
stress-70 protein, mitochondrial isoform X2
heat shock protein family A (Hsp70) member 9, transcript variant X1
stress-70 protein, mitochondrial isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00154
eukaryotic translation termination factor 1, transcript variant X1
eukaryotic peptide chain release factor subunit 1 isoform X1
eukaryotic translation termination factor 1, transcript variant X2
eukaryotic peptide chain release factor subunit 1 isoform X2
F-box and WD repeat domain containing 11, transcript variant X1
F-box and WD repeat domain containing 11, transcript variant X4
F-box and WD repeat domain containing 11, transcript variant X2
F-box and WD repeat domain containing 11, transcript variant X3
F-box and WD repeat domain containing 11, transcript variant X5
F-box/WD repeat-containing protein 11 isoform X1
F-box/WD repeat-containing protein 11 isoform X3
F-box/WD repeat-containing protein 11 isoform X2
F-box/WD repeat-containing protein 11 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125333549, transcript variant X7
uncharacterized LOC125333549, transcript variant X6
uncharacterized LOC125333549, transcript variant X3
uncharacterized LOC125333549, transcript variant X2
uncharacterized LOC125333549, transcript variant X4
uncharacterized LOC125333549, transcript variant X1
uncharacterized LOC125333549, transcript variant X5
kazal-type serine protease inhibitor domain-containing protein 1-like
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X1
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X2
gamma-aminobutyric acid receptor subunit pi isoform X1
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X4
gamma-aminobutyric acid type A receptor subunit pi, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit pi isoform X2
gamma-aminobutyric acid receptor subunit pi isoform X3
potassium voltage-gated channel interacting protein 1, transcript variant X3
potassium voltage-gated channel interacting protein 1, transcript variant X10
potassium voltage-gated channel interacting protein 1, transcript variant X4
potassium voltage-gated channel interacting protein 1, transcript variant X8
potassium voltage-gated channel interacting protein 1, transcript variant X7
potassium voltage-gated channel interacting protein 1, transcript variant X6
potassium voltage-gated channel interacting protein 1, transcript variant X9
potassium voltage-gated channel interacting protein 1, transcript variant X5
potassium voltage-gated channel interacting protein 1, transcript variant X1
potassium voltage-gated channel interacting protein 1, transcript variant X2
Kv channel-interacting protein 1 isoform X3
Kv channel-interacting protein 1 isoform X4
Kv channel-interacting protein 1 isoform X5
Kv channel-interacting protein 1 isoform X1
Kv channel-interacting protein 1 isoform X2
Kv channel-interacting protein 1 isoform X6
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X3
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X2
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X1
calcium-activated potassium channel subunit beta-1 isoform X2
calcium-activated potassium channel subunit beta-1 isoform X1
uncharacterized LOC125333629, transcript variant X2
uncharacterized LOC125333629, transcript variant X3
uncharacterized LOC125333629, transcript variant X4
uncharacterized LOC125333629, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
epidermal growth factor receptor kinase substrate 8-like protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: epidermal growth factor receptor kinase substrate 8-like protein 2
uncharacterized LOC125333631, transcript variant X2
uncharacterized LOC125333631, transcript variant X4
uncharacterized LOC125333631, transcript variant X1
uncharacterized LOC125333631, transcript variant X3